Is a Policy of Surveillance Warranted in Early Stage Testicular Cancer Following Orchiectomy?

  • A. Pawinski
  • W. Wynendaele
  • A. Van Oosterom
Part of the Medical Radiology book series (MEDRAD)


The progress in imaging modalities and in the available treatment options in recent decades has ren-dered, stage I testicular cancer, the most frequent malignancy in the young male population, highly curable. Seventy percent of seminomas and 50% of nonseminoma testicular tumors are diagnosed as stage 1 disease (Bosl and Motzer 1997; Fossa and Horwich 1989). High inguinal orchiectomy has been the standard initial diagnostic and treatment approach for a patient with a suspected testicular tumor. In the past, even patients with no clinical signs of cancer dissemination were additionally subjected to adjuvant retroperitoneal lymph node dissection (RPLND) or locoregional radiotherapy. There were certainly reasons justifying this cautious approach. Patients with stage I testicular cancer, a highly aggressive disease, had a good prognosis, but due to the insufficient accuracy of clinical staging and a low probability of curing patients with relapsed disease, survival rates were usually proportional to the incidence of relapse and ranged at that time from 70% to 90% (Carter 1983; Maier and Sulak 1973; Whitmose 1979; Peckham and McElwain 1974). Although not proven by randomized trials, some authors believed that a combined approach, which often included chemotherapy, gave a decrease in relapse rate and a higher overall survival.


Germ Cell Tumor Testicular Cancer Testicular Tumor Nonseminomatous Germ Cell Tumor Testicular Seminoma 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Albers P, Bierhoff E, Neu D, Fimmers R, Wernert N, Muller SC (1997) MIB-1 immunochemistry in clinical stage I nonseminomatous testicular germ cell tumors predicts patients at low risk for metastasis. Cancer 79: 1710–1716PubMedCrossRefGoogle Scholar
  2. Allhoff EP, Liedke S, de Riese W, Stief C, Schneider B (1991) Stage I seminoma of the testis. Adjuvant radiotherapy or surveillance. Br J Urol 68: 190–194PubMedCrossRefGoogle Scholar
  3. Baniel J, Roth BJ, Foster RS, Donohue JP (1996) Cost- and risk- benefit considerations in the management of clinical stage I nonseminomatous testicular tumors. Ann Surg Oncol 3: 86–93PubMedCrossRefGoogle Scholar
  4. Bender H, Schomburg A, Albers P, Ruhlmann J, Biersack H-J (1997) Possible role of FDG-PET in the evaluation of uro- logic malignancies. Anticancer Res 17: 1655–1660PubMedGoogle Scholar
  5. Bokemeyer C, Kuczyk MA, Serth J, Hartmann JT, Schmoll HJ, Jonas U, Kanz L (1996) Treatment of clinical stage I testicular cancer and a possible role for new biological prognostic parameters. J Cancer Res Clin Oncol 122: 575–584PubMedCrossRefGoogle Scholar
  6. Bosl GJ, Motzer RJ (1997) Testicular germ-cell cancer. N Engl J Med 337: 242–253PubMedCrossRefGoogle Scholar
  7. Bosl GJ, Bajorin D, Sheinfeld J, Motzer R (1997) Cancer of the testis. In: De Vita VT, Hellman S, Rosenberg SA (eds) Cancer: principles and practice of oncology. 5th edn. Lippincott-Raven, Philadelphia, pp 1397–1425Google Scholar
  8. Carter SK (1983) The management of testicular cancer. Recent Results Cancer Res 85: 70–97PubMedGoogle Scholar
  9. Chow WH, Lindblad P, Gridley G, et al. (1997) Risk of second malignant neoplasms among long-term survivors of tes¬ticular cancer. J Natl Cancer Inst 89: 1429–1439CrossRefGoogle Scholar
  10. Cullen MH (1996) Management of stage I non-seminoma: surveillance and chemotherapy. In: Horwich A (ed) Testicular cancer: investigation and management. Chapman and Hall Medical, London, pp 149–166Google Scholar
  11. Cullen M, James N (1996) Adjuvant therapy for stage I testicular cancer. Cancer Treat Rev 22:253–264PubMedCrossRefGoogle Scholar
  12. Cullen MH, Stenning SP, Parkinson MC, et al(1996) Short- course adjuvant chemotherapy in high-risk stage I nonseminomatous germ cell tumors of the testis: a MRC report. J Clin Oncol 14: 1106–1113PubMedGoogle Scholar
  13. Dieckmann KP, Krain J, Kuster J, Bruggeboes B (1996) Adjuvant carboplatin treatment for seminoma clinical stage I. J Cancer Res Clin Oncol 122: 63–66PubMedCrossRefGoogle Scholar
  14. Donohue JP (1987) Controversies in testis cancer manage¬ment. In: Kernion J, Paulson D. Genitourinary cancer man¬agement. Lea & Febiger, Philadelphia, pp 161–186Google Scholar
  15. Donohue JP, Thornhill JA, Foster RS, Rowland RG, Bihrle R (1993a) Primary retroperitoneal lymph node dissection in clinical stage A non-seminomatous germ cell testis cancer: review of the Indiana University experience. Br J Urol 71: 326–335PubMedCrossRefGoogle Scholar
  16. Donohue JP, Thornhill JA, Foster RS, Rowland RG, Bihrle R (1993b) Retroperitoneal lymphadenectomy for clinical stage A testis cancer: modifications of technique and impact on ejaculation. J Urol 149: 237–243PubMedGoogle Scholar
  17. Dosmann MA, Gunar K, Zagars MD (1993) Postorchiectomy radiotherapy for stage I and II testicular seminoma. Int J Radiat Oncol Biol Phys. 26: 381–390PubMedCrossRefGoogle Scholar
  18. Fossa SD, Horwich AH (1989) The staging and treatment of testicular cancer: management of stage I disease. In: Smith PH (ed) Combination therapy in urological malignancy. Springer, London Berlin Heidelberg New York, pp 173–189Google Scholar
  19. Fossa SD, Aass N, Kaalhus O (1989) Radiotherapy for testicular seminoma stage I: Treatment results and long term post-irradiation morbidity in 365 patients. Int J Radiat Oncol Biol Phys 16: 383–388PubMedCrossRefGoogle Scholar
  20. Fossa S, Horwich A, Russell J, Roberts JP, Jakes R, Stenning S (1996a) Optimal field size in adjuvant radiotherapy of stage I seminoma - a randomized trial. Proc Am Soc Clin Oncol 15: 239Google Scholar
  21. Fossa SD, Moynihan C, Serbuti S (1996b) Patients’ and doctors’ perception of long-term morbidity in patients with testicular cancer clinical stage I. Support Care Cancer 4: 118–128PubMedCrossRefGoogle Scholar
  22. Foster RS, Donohue JP (1992) Surgical treatment of clinical stage I nonseminomatous testis cancer. Semin Oncol 19: 166–170PubMedGoogle Scholar
  23. Freedman LS, Parkinson MC, Jones WG, et al. (1987) Histopathology in the prediction of relapse of patients with stage I testicular teratoma treated by orchiectomy alone. Lancet 11: 294–298CrossRefGoogle Scholar
  24. Gelderman WAH, Schraffordt Koops H, Sleijfer DT (1987) Orchiectomy alone in stage I nonseminomatous testicular germ cell tumours. Cancer 59: 578–580PubMedCrossRefGoogle Scholar
  25. Hamilton C, Horwich A, Easton D, Peckham MJ (1986) Radiotherapy for stage I seminoma testis: results of treatment and complications. Radiother Oncol 6: 115–120PubMedCrossRefGoogle Scholar
  26. Hanks GE, Peters T, Owen J (1992) Seminoma of the testis: long term beneficial and deleterious results of radiation. Int J Radiat Oncol Biol Phys 24: 913–919PubMedCrossRefGoogle Scholar
  27. Horwich A, Dearnaley DP (1992) Treatment of seminoma. Semin. Oncol. 19: 171–183PubMedGoogle Scholar
  28. Horwich A, Alsanjari N, Hern RA, Nicholls J, Dearnaley DP, Fisher C (1992) Surveillance following orchiectomy for stage I testicular seminoma. Br J Cancer 65: 775–778PubMedCrossRefGoogle Scholar
  29. Hoskin P, Dilly S, Easton D, Horwich A, Hendry W, Peckham MJ (1986) Prognostic factors in stage I non-seminomatous germ-cell testicular tumors managed by orchiectomy and surveillance: implications for adjuvant chemotherapy. J Clin Oncol 4: 1031–1036PubMedGoogle Scholar
  30. Howard GCW, Clarke K, Elia MH (1995) A Scottish National Audit of current patterns of management for patients with testicular non-semiomatous germ cell tumors. Br J Cancer 72: 1303–1306PubMedCrossRefGoogle Scholar
  31. Jacobsen GK, Rorth M, Osterlind K (1990) Histopathological features in stage I non-seminomatous testicular germ cell tumors correlated to relapse. APMIS 98: 377PubMedCrossRefGoogle Scholar
  32. Klepp O, Olsson AM, Henrikson H, et al. (1990) Prognostic factors in clinical stage I nonseminomatous germ cell tumors of the testis: multivariate analysis of a prospective multicenter study. J Clin Oncol 8: 509–518PubMedGoogle Scholar
  33. Kratzik C, Kuhrer I, Wiltsche C, Amman G (1993) Carboplatin-monotherapie bei Seminomen in Stadium I. Acta Chir Aust 25: 27–28CrossRefGoogle Scholar
  34. Madej G, Pawinski A (1991a) Risk-related adjuvant chemo-therapy for stage I non-seminoma of the testis. Clin Oncol R Coll Radiol 3: 270–272PubMedCrossRefGoogle Scholar
  35. Madej G, Pawinski A (1991b) Preliminary evaluation of prognostic factors in selecting the methods of treatment of patients with stage I testicular seminoma. Nowotwory 40: 181–185Google Scholar
  36. Maier JG, Sulak MH (1973) Radiation therapy in malignant testis tumors. Part II Carcinoma. Cancer 32: 1217–1226PubMedCrossRefGoogle Scholar
  37. McLeod DG, Weiss RB, Stablein DM, et al. (1991) Staging relationships and outcome in early stage testicular cancer: a report from the TCIG. J Urol 145: 1178–1183PubMedGoogle Scholar
  38. Mead GM, Stenning SP, Parkinson MC (1992) The second MRC study of prognostic factors in nonseminomatous germ cell tumors. J Clin Oncol 10: 85–88PubMedGoogle Scholar
  39. Motzer RJ, Bosl GJ, Geller NL (1988) Advanced seminoma. The role of chemotherapy, and adjunctive surgery. Ann Intern Med 108: 513–521PubMedGoogle Scholar
  40. Moynihan C (1987) Testicular cancer: the psychosocial problems of patients and their relatives. Cancer Surv 6: 478–510Google Scholar
  41. Nichols CR, Roth BJ, Einhorn LH (1992) Managing testicular cancer. Contemp. Oncol May/June: 13Google Scholar
  42. Nuutinen JM, Leskinen S, Elomaa I, et al. (1997) Detection of residual tumors in postchemotherapy testicular cancer by FDG-PET. Eur J Cancer 33: 1234–1241PubMedCrossRefGoogle Scholar
  43. Oliver RTD, Love S, Ong J (1990) Alternatives to radiotherapy in the management of seminoma. Br J Urol 65: 61–67PubMedCrossRefGoogle Scholar
  44. Oliver RTD, Ong J, Blandy JP, Altman DG (1996) Testis conservation studies in germ cell cancer justified by improved primary chemotherapy response and reduced delay, 1978–1994. Br J Urol 78: 119–124PubMedGoogle Scholar
  45. Oliver RTD, Raja MA, Ong J, Gallagher CJ (1992) Pilot study to evaluate impact of a policy of adjuvant chemotherapy for high risk stage I malignant teratoma on overall relapse rate of stage 1 cancer patients. J Urol 148: 1453–1456PubMedGoogle Scholar
  46. Paluchowska B, Madej G, Wiechno P, et al. (1995) Adjuvant chemotherapy dependent on the presence of risk factors in a non-seminomatous testicular tumors of a clinical stage I. Urologia Pol. 3A Suppl: 117Google Scholar
  47. Pawinski A, Madej G, Gajl D (1992) Evaluation of the results of combined treatment of patients with testicular seminoma in the II stage of clinical advancement. Pol Tyg Lek 47: 540–541PubMedGoogle Scholar
  48. Peckham MJ, McElwain TJ (1974) Radiotherapy of testicular tumors. Proc R Soc Med 67: 400–404Google Scholar
  49. Peckham MJ, Barret A, Husband JE, Hendry WF (1982) Orchiectomy alone in testicular stage I non-seminomatous germ cell tumors. Lancet 11: 678–680CrossRefGoogle Scholar
  50. Pizzocaro G, Zanoni F, Salvioni R, Milani A, Piva L, Pilotti S (1987) Difficulties of a surveillance study omitting retroperitoneal lymphadenectomy in clinical stage I non-seminomatous germ cell tumors of the testis. J Urol 138: 1393–1395PubMedGoogle Scholar
  51. Pizzocaro G, Salvioni R, Nicolai N (1995) The role of adjuvant treatment in low-stage germ cell testicular tumors. Eur Urol 28: 267–272PubMedGoogle Scholar
  52. Pont J, Holtl W, Kosak D, Machacek E, Kienzer H, Julcher H, Honetz N (1990) Risk adapted treatment choice in stage I nonseminomatous testicular germ cell cancer by regarding vascular invasion in the primary tumor. J Clin Oncol 8: 16–19PubMedGoogle Scholar
  53. Pont J, Albrecht W, Postner G, Sellner F, Angel K, Holtl W (1996) Adjuvant chemotherapy for high risk clinical stage I nonseminomatous testicular germ cell cancer: long term results of a prospective trial. J Clin Oncol 14: 441–448PubMedGoogle Scholar
  54. Raghavan D, Colls B, Levi J (1988) Surveillance for stage I nonseminomatous germ cell tumors of the testis: the optimal protocol has not yet been difined. Br J Urol 61: 522–526PubMedCrossRefGoogle Scholar
  55. Read G, Stenning SP, Cullen MH, Parkinson MC, Horwich A, Kaye SB, Cook PA (1992) MRC prospective study of sur-veillance for stage I testicular teratoma. J Clin Oncol 10: 1762–1768PubMedGoogle Scholar
  56. Richie JP (1990) Clinical stage 1 testicular cancer: the role of modified retroperitoneal lymphadenectomy. J Urol 144: 1160–1163PubMedGoogle Scholar
  57. Rorth M (1992) Therapeutic alternatives in clinical stage I nonseminomatous disease. Semin Oncol 19: 190–198PubMedGoogle Scholar
  58. Rorth M, Krag Jacobsen G, von der Maase H, Madsen EL, Nielsen OS, Pedersen M, Schultz H (1991) Surveillance alone versus radiotherapy after orchiectomy for clinical stage I nonseminomatous testicular cancer. J Clin Oncol 9: 1543–1548PubMedGoogle Scholar
  59. Schover LR, Gonzales M, von Eschenbach A (1986) Sexual and marital relationships after radiotherapy for seminoma. Urology 27: 117–123PubMedCrossRefGoogle Scholar
  60. Sesterhenn IA, Weiss RB, Mostoíi FK, et al. (1992) Prognosis and other clinical correlates of pathologic review in stage I and II testicular carcinoma: a report from the TCIS. J Clin Oncol 10: 69–78PubMedGoogle Scholar
  61. Sharda NN, Kinsella TJ, Ritter MA (1996) Adjuvant radiation versus observation: a cost analysis of alternate management schemes in early-stage testicular seminoma. J Clin Oncol 14: 2933–2939PubMedGoogle Scholar
  62. Small E, Torti FM (1995) Testes. Management of low stage disease. In: Abeloff MD, Armitage JO, Lichter AS, Niederhuber JE (eds) Clinical oncology. Churchill Livingstone, New York, pp 1504–1511Google Scholar
  63. Sogani PC, Fair WR (1988) Surveillance alone in the treatment of clinical stage I nonseminomatous germ cell tumor of the testis. Semin Urol 6: 53–56PubMedGoogle Scholar
  64. Strauss LG, Conti PS (1991) The applications of PET in clinical oncology. J Nucl Med 32: 623–648PubMedGoogle Scholar
  65. Stuart NSA, Woodroffe CM, Grundy R, Cullen MH (1990) Long term toxicity of chemotherapy for testicular cancer - the cost of cure. Br J Cancer 61: 479–484PubMedCrossRefGoogle Scholar
  66. Studer UE, Fey MF, Calderoni A, Kraft R, Mazzucchelli L, Sontag RW (1993) Adjuvant chemotherapy after orchiectomy in high risk patients with clinical stage I nonseminomatous testicular cancer. Eur Urol 23: 444–449PubMedGoogle Scholar
  67. Sturgeon JFG, Jewett MAS, Alison RE, et al. (1992) Surveillance after orchiectomy for patients with clinical stage I nonseminomatous testis tumors. J Clin Oncol 10: 564–568PubMedGoogle Scholar
  68. Swanson D, Johnson D, von Eschenbach A (1987) Five years experience with orchiectomy of clinical stage I nonseminomatous germ cell testicular tumors. J Urol 137: 211AGoogle Scholar
  69. van Leeuwen FE, Stiggelbout AM, van den Belt-Dusebout AW, et al. (1993) Second cancer risk following testicular cancer: a follow-up study of 1909 patients. J Clin Oncol 11: 415–424PubMedGoogle Scholar
  70. Van Oosterom A, Neijt JP, Theodore C, Keizer HJ, Ten Bokkel Huinink W, Collette L (1998) Management of stage I nonseminomatous testicular cancer with unilateral orchidectomy alone. Eur J Cancer (to be published)Google Scholar
  71. Von der Maase H, Specht L, Jacobsen GK, et al. (1993) Surveillance following orchiectomy for stage I seminoma of the testis. Eur J Cancer 29A: 1931–1934CrossRefGoogle Scholar
  72. Warde P, Gospodarowicz MK, Panzarella T, et al. (1995) Stage I testicular seminoma: results of adjuvant irradiation and surveillance. J Clin Oncol 13: 2255–2262PubMedGoogle Scholar
  73. Whitmore WF (1979) Surgical treatment of adult germ cell tumors. Semin Oncol 6: 55–69PubMedGoogle Scholar
  74. Williams SD, Stablein DM, Einhorn LH, et al. (1987) Immediate adjuvant chemotherapy vs. observation with treatment at relapse in pathologic stage II testicular cancer. N Engl J Med 317: 1433–1436PubMedCrossRefGoogle Scholar
  75. Wishnow KI, Johnson DE, Dunphy CH, et al. (1989) Identifying patients with low-risk clinical stage I nonseminomatous testicular tumors who should be treated by surveillance. Urology XXXIV: 339–343CrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1999

Authors and Affiliations

  • A. Pawinski
    • 1
  • W. Wynendaele
    • 1
  • A. Van Oosterom
    • 1
  1. 1.Department of OncologyUniversity Hospitals Gasthuisberg, Catholic University of LeuvenLeuvenBelgium

Personalised recommendations